ISBN-13: 9783319842714 / Angielski / Miękka / 2018 / 483 str.
ISBN-13: 9783319842714 / Angielski / Miękka / 2018 / 483 str.
This book evaluates the trend to treat low risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. It examines the latest clinical applications of image-guided diagnosis and treatment.
Table of Contents
Imaging and Focal Therapy of Early Prostate Cancer, 2E
Editor: Thomas J. Polascik
Foreword
Jean J. M. C. H. de la Rosette
Preface
Acknowledgments
Contributors
Section 1: Why Focal Therapy?
Chapter 1. Evolution in the Concept of Focal Therapy: the Story of Breast Cancer and Prostate Cancer
Isabel García-Fleury, Chi-hang Yee, Marco Antonio López-Tovar, Adriana Pesci-Feltri, Arjun Sivaraman, and Rafael Sanchez-Salas
Chapter 2 Targeted Therapy for Localized Kidney Cancer
Zhamshid Okhunov, Roshan M. Patel, and Jaime Landman
Chapter 3. Focal Therapy for Prostate Cancer: A Guide for Patients
Kae Jack Tay and Thomas J. Polascik
Section 2: Global Perspective of Active Surveillance and Focal Therapy
Chapter 4. Low-Risk Prostate Cancer in North America: Rationale, Uptake, and Limitations of Active Surveillance and Opportunities for Focal Therapy
Raj Satkunasivam and Laurence Klotz
Chapter 5. Focal Therapy and Active Surveillance in Europe
Jan Philipp Radtke, Angelo Territo, Markus R. Hohenfellner, and Alberto BredaChapter 6. Focal Therapy and Active Surveillance of Prostate Cancer in East and Southeast Asia
Masaki Kimura, Kae Jack Tay, Satoru Muto, and Shigeo Horie
Section 3: Scientific Foundation for the Focal Therapy Concept
Chapter 7. Pathologic Rationale for Focal Therapy of Prostate Cancer: Elucidating Tumor Characteristics and Biology
Vladimir Mouraviev, Arnauld Villers , Thomas M. Wheeler, Rodolfo Montironi, Pierre Nevoux, Ariel Schulman, and Thomas J. Polascik
Chapter 8. Identifying and Characterizing the Index Lesion
Lina M. Carmona Echeverria, Hayley Whitaker, and Hashim U. Ahmed
Chapter 9. Utilizing Biopsy-Based Genomic Assays to Risk-Stratify Patients
Robert Qi, Stephen J. Freedland, and Judd W. Moul
Chapter 10. Patient Selection for Focal Therapy of Prostate Cancer
Arjun Sivaraman and Rafael Sanchez-Salas
Chapter 11. Prostate Focal Therapy: Definitions and Common Terminology
John F. Ward
Section 4: Multiparametric MRI and ARFI Imaging of the Prostate
Chapter 12. Reading and Reporting Standards: The Prostate Imaging Reporting And Data System – What Is It and What Can It Do?
Wulphert Venderink and Jurgen J. Fütterer
Chapter 13. Role of Magnetic Resonance Imaging in Prostate Cancer Assessment
Sonia Gaur, Sherif Mehralivand, Baris Turkbey, and Peter L. Choyke
Chapter 14. Optimizing Multiparametric Magnetic Resonance Imaging for a Focal Therapy Practice: Quality Improvement
Jamie N. Holtz and Rajan T. Gupta
Chapter 15. Acoustic Radiation Force Impulse Imaging for Targeting: Correlation with Histology
Mark L. Palmeri and Kathryn R. Nightingale
Section 5: Prostate Biopsy Techniques
Chapter 16. In-Bore Magnetic Resonance Imaging-Targeted Biopsy
Igor Trilisky, Aytekin Oto, and Scott Eggener
Chapter 17. Multiparametric MRI-TRUS Fusion Biopsy, Outcomes, and Commercial Systems
Akhil Muthigi, Ardeshir R. Rastinehad, Arvin K. George, Masakatsu Oishi, Osamu Ukimura, and Peter A. Pinto
Chapter 18. Detecting, Localizing, and Treating the Multiparametric Magnetic Resonance Imaging Invisible Lesion: Utilizing Three-Dimensional Transperineal Mapping
Nelson N. Stone and E. David Crawford
Chapter 19. Multiparametric Transrectal Ultrasound Biopsy
Arnoud W. Postema, Jochen Walz, and Hessel Wijkstra
Chapter 20. Robotic Magnetic Resonance Imaging Targeting for Biopsy and Therapy Wesley W. Ludwig, Mohamad E. Allaf, and Dan Stoianovici
Section 6: Technologies for Focal Therapy: Transperineal Approach
Chapter 21. In-Bore Transperineal Magnetic Resonance Imaging-Guided Laser Ablation
Nathan Perlis, John Trachtenberg, and Sangeet Ghai
Chapter 22. Focal Cryoablation
Kae Jack Tay, Efrat Tsivian, and Thomas J. Polascik
Chapter 23. Photodynamic Therapy for Early Prostate Cancer
Caroline M. Moore and Mark Emberton
Section 7: Technologies for Focal Therapy: Transrectal Approach
Chapter 24 High-Intensity Focused Ultrasound
Paolo Capogrosso and Eric Barret
Chapter 25. Transrectal Laser Focal Therapy of Prostate Cancer
John F. Feller, Bernadette M. Greenwood, and R. Jason Stafford
Section 8: New Approaches and Applications of Focal Therapy
Chapter 26. Focal Therapy for Prostate Cancer: a Molecular Biology Approach with TRAIL
Vikram Narayan, Badrinath R. Konety, and Thomas S. Griffith
Chapter 27. Focal Brachytherapy and Intensity Modulated Radiation Therapy
R. Alex Hsi
Chapter 28. Focal Therapy for Anterior Cancers (Originated from Transition Zone)
Arnauld Villers and Kae Jack Tae
Section 9: Manipulating the Microenvironment for Optimization
Chapter 29. The Story of Adjuvants to Boost the Performance of Cryoablation
Kimberly L. Santucci, John M. Baust, Kristi K. Snyder, Anthony Robilotto, Robert G. VanBuskirk, and John G. Baust
Chapter 30. 5-Alpha-Reductase Inhibition as a Secondary Preventive Strategy
Nathan Perlis and Antonio Finelli
Section 10: Determining Outcomes of Focal Therapy
Chapter 31. Measuring Patient-Based Outcomes: Setting Realistic Expectations When Balancing Functional Outcomes with Cancer Control
Behfar Ehdaie and Arjun Sivaraman
Chapter 32. Pathologic Assessment and Implications Following Focal Therapy of Prostate Cancer
Rafael E. Jimenez, Andrew Evans, James Kench, Rodolfo Montironi, and Mahul B. Amin
Chapter 33. Post-Treatment Surveillance Using Multiparametric Magnetic Resonance Imaging
Alex Kirkham
Chapter 34. Determining Focal Therapy Failure and Salvage Options
Theo M. de Reijke, Arnoud W. Postema, and J. Stephen Jones
Chapter 35. Positioning Focal Therapy from Consensus to Guidelines
Matthijs J. V. Scheltema, Anouk E. Hentschel, and Jean J. M. C. H. de la Rosette
This text encompass an up-to-date, comprehensive review of the state-of-the-art for gland preserving therapies. Fully updated and revised, this text evaluates the scientific evidence for the evolving trend to treat intermediate risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. Various ablative devices such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and laser ablation, among others, is discussed in regard to their strengths and limitations as a therapeutic modality. Emphasis is placed on patient selection and outcomes utilizing both advanced imaging techniques and pathologic evaluation.
Current and new approaches to image cancer foci within the prostate (multiparametric ultrasonography, multiparametric magnetic resonance image, etc) are presented along with various biopsy techniques, including robotics to map prostate cancer. Patient selection based on imaging and genomic classification, adjuvants to enhance therapy, treatment strategy, outcomes and patient centered concerns is discussed, providing an acceptable balance between cancer control and improved quality of life for patients.1997-2024 DolnySlask.com Agencja Internetowa